ArticleNature communications2022

Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein.

Julia T Castro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.